TLR and RLR signaling are reprogrammed in opposite directions after detection of viral infection

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4387-4395

  Hotz, Christian ^a,b   Roetzer, Laurin C ^b   Huber, Thomas ^b   Sailer, Andreas ^b   Oberson, Anne ^a   Treinies, Marina ^a   Heidegger, Simon ^b,c   Herbst, Tina ^a   Endres, Stefan ^b   Bourquin, Carole ^a,b  

^a University of Fribourg   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; PHOSPHOTRANSFERASE; POLYINOSINIC POLYCYTIDYLIC ACID; RIG I LIKE RECEPTOR; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR; ALPHA INTERFERON; DDX58 PROTEIN, MOUSE; DEAD BOX PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IN VIVO STUDY; INHIBITION KINETICS; INNATE IMMUNITY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENDAI VIRUS INFECTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; 129 MOUSE; ANIMAL; C57BL MOUSE; CELL LINE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENDAI VIRUS; TUMOR CELL LINE; VIROLOGY; VIRUS INFECTION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; GENE EXPRESSION; IMMUNOBLOTTING; INTERFERON-ALPHA; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGES; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; RECEPTORS, PATTERN RECOGNITION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENDAI VIRUS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; VIRUS DISEASES;

EID: 84945161704     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500079     Document Type: Article

References (44)

1. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54: 1-13.
2. Arpaia, N., and G. M. Barton. 2011. Toll-like receptors: key players in antiviral immunity. Curr. Opin. Virol. 1: 447-454.
3. Loo, Y. M., and M. Gale, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
4. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
5. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
6. Blasius, A. L., and B. Beutler. 2010. Intracellular toll-like receptors. Immunity 32: 305-315.
7. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
8. Nish, S., and R. Medzhitov. 2011. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 34: 629-636.
9. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
10. Bagchi, A., E. A. Herrup, H. S. Warren, J. Trigilio, H. S. Shin, C. Valentine, and J. Hellman. 2007. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 178: 1164-1171.
11. De Nardo, D., C. M. De Nardo, T. Nguyen, J. A. Hamilton, and G. M. Scholz. 2009. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages. J. Immunol. 183: 8110-8118.
12. Pohar, J., N. Pirher, M. Benčina, M. Manček-Keber, and R. Jerala. 2013. The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists. J. Biol. Chem. 288: 442-454.
13. Suet Ting Tan, R., B. Lin, Q. Liu, L. Tucker-Kellogg, B. Ho, B. P. Leung, and J. Ling Ding. 2013. The synergy in cytokine production through MyD88-TRIF pathways is co-ordinated with ERK phosphorylation in macrophages. Immunol. Cell Biol. 91: 377-387.
14. Bourquin, C., C. Hotz, D. Noerenberg, A. Voelkl, S. Heidegger, L. C. Roetzer, B. Storch, N. Sandholzer, C. Wurzenberger, D. Anz, and S. Endres. 2011. Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance. Cancer Res. 71: 5123-5133.
15. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776.
16. Kim, Y. G., J. H. Park, T. Reimer, D. P. Baker, T. Kawai, H. Kumar, S. Akira, C. Wobus, and G. Núñez. 2011. Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe 9: 496-507.
17. Perkins, D. J., S. K. Polumuri, M. E. Pennini, W. Lai, P. Xie, and S. N. Vogel. 2013. Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production. PLoS Pathog. 9: e1003479.
18. Poeck, H., R. Besch, C. Maihoefer, M. Renn, D. Tormo, S. S. Morskaya, S. Kirschnek, E. Gaffal, J. Landsberg, J. Hellmuth, et al. 2008. 5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat. Med. 14: 1256-1263.
19. Hornung, V., J. Ellegast, S. Kim, K. Brzózka, A. Jung, H. Kato, H. Poeck, S. Akira, K. K. Conzelmann, M. Schlee, et al. 2006. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
20. Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R. A. Flavell, M. S. Diamond, and M. Colonna. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103: 8459-8464.
21. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
22. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
23. Negishi, H., H. Yanai, A. Nakajima, R. Koshiba, K. Atarashi, A. Matsuda, K. Matsuki, S. Miki, T. Doi, A. Aderem, et al. 2012. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat. Immunol. 13: 659-666.
24. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424: 743-748.
25. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
26. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
27. Gitlin, L., L. Benoit, C. Song, M. Cella, S. Gilfillan, M. J. Holtzman, and M. Colonna. 2010. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog. 6: e1000734.
28. Dobrovolskaia, M. A., A. E. Medvedev, K. E. Thomas, N. Cuesta, V. Toshchakov, T. Ren, M. J. Cody, S. M. Michalek, N. R. Rice, and S. N. Vogel. 2003. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J. Immunol. 170: 508-519.
29. Long, L., Y. Deng, F. Yao, D. Guan, Y. Feng, H. Jiang, X. Li, P. Hu, X. Lu, H. Wang, et al. 2014. Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling. Immunity 40: 515-529.
30. Kim, M. J., S. Y. Hwang, T. Imaizumi, and J. Y. Yoo. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 82: 1474-1483.
31. Didierlaurent, A., J. Goulding, S. Patel, R. Snelgrove, L. Low, M. Bebien, T. Lawrence, L. S. van Rijt, B. N. Lambrecht, J. C. Sirard, and T. Hussell. 2008. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205: 323-329.
32. Nansen, A., and A. Randrup Thomsen. 2001. Viral infection causes rapid sensitization to lipopolysaccharide: central role of IFN-alpha beta. J. Immunol. 166: 982-988.
33. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
34. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
35. Zhao, J., C. Wohlford-Lenane, J. Zhao, E. Fleming, T. E. Lane, P. B. McCray, Jr., and S. Perlman. 2012. Intranasal treatment with poly(I·C) protects aged mice from lethal respiratory virus infections. J. Virol. 86: 11416-11424.
36. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. Royal Soc. London B 147: 258-267.
37. Isaacs, A., J. Lindenmann, and R. C. Valentine. 1957. Virus interference. II. Some properties of interferon. Proc. Royal Soc. London B 147: 268-273.
38. Trinchieri, G. 2010. Type I interferon: friend or foe? J. Exp. Med. 207: 2053-2063.
39. Anz, D., R. Thaler, N. Stephan, Z. Waibler, M. J. Trauscheid, C. Scholz, U. Kalinke, W. Barchet, S. Endres, and C. Bourquin. 2009. Activation of melanoma differentiation-associated gene 5 causes rapid involution of the thymus. J. Immunol. 182: 6044-6050.
40. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
41. Högner, K., T. Wolff, S. Pleschka, S. Plog, A. D. Gruber, U. Kalinke, H. D. Walmrath, J. Bodner, S. Gattenlöhner, P. Lewe-Schlosser, et al. 2013. Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 9: e1003188.
42. Wilson, E. B., D. H. Yamada, H. Elsaesser, J. Herskovitz, J. Deng, G. Cheng, B. J. Aronow, C. L. Karp, and D. G. Brooks. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340: 202-207.
43. Teijaro, J. R., C. Ng, A. M. Lee, B. M. Sullivan, K. C. F. Sheehan, M. Welch, R. D. Schreiber, J. C. de la Torre, and M. B. A. Oldstone. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340: 207-211.
44. Cousens, L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94: 634-639.